Tyra Biosciences Inc (TYRA NASDAQ) stock market data APIs
$21.0921
0.07(0.3%)
as of October 30, 2026
Try our APIs with
free plan!
Tyra Biosciences Inc Financial Data Overview
Price chart is built with
Anychart
Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is FGFR3, which is in clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in clinical trial for intrahepatic cholangiocarcinoma; and TYRA-430 for the treatment of hepatocellular carcinoma. Tyra Biosciences, Inc. was incorporated in 2018 and is headquartered in Carlsbad, California.
Prev. Close
21.0921
Open
21.1637
High
21.4451
Low
20.2145
52 wk Range
13.35-40.65
Market Cap
1 449 M
Shares Outstanding
68 756 K
Beta
0.751
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Tyra Biosciences Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Tyra Biosciences Inc data using free add-ons & libraries
Get Tyra Biosciences Inc Fundamental Data
Tyra Biosciences Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -159 922 000
- Earnings Per Share: -2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-11-04
- EPS/Forecast: -0.66
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Tyra Biosciences Inc News
New
Tyra Biosciences (TYRA) Stock Looks Rich Against Its Book Value
Tyra Biosciences has delivered a 54.9% gain over the past 3 years, which means anyone looking at the stock today now has to ask whether that share price is still grounded in the company's book value. ...
Top 4 Healthcare Stocks Backed by Raymond James Analysts
Investing.com -- Raymond James has identified its top stock picks in the healthcare sector, highlighting companies with upcoming clinical trial results and promising drug development programs. The fir...
Raymond James Updates Healthcare Top Picks for October
Investing.com -- Raymond James has updated its Healthcare Top Picks list for October, adding three new stocks while removing others from the monthly selection. The firm added Xencor, Calyxt, and Unite...
Tyra Plummets To 10-Month Low On Mixed Cancer Test; Why Analysts Are Upbeat
Tyra stock plummeted to a 10-month low Wednesday on mixed test results for its experimental bladder cancer treatment. Continue Reading
Get Tyra Biosciences Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.